Tag Archives: APRI

hot stocks to invest in

April 1969 saw the release of what would soon become Credence Clearwater Revival’s second gold single. Bad Moon Rising’s popularity quickly secured it a permanent spot in rock history. But it was also headed somewhere else, if not everywhere else, to places the young rockers never saw coming. In hindsight, it can only be said that while their music was great, their lawyer was lousy.

Why is that? Because, for years now, writers for both the big and small screen and all manner of productions have found the song’s addictive rhythm and lyrics impossible to resist and as a bonus, easy picking. Listen and you’ll hear it in An American Werewolf in London, My Fellow Americans, Twilight Zone: The Movie, Blade, Sweet Home Alabama, My Girl, Man of the House, Mr. Woodcock and (in the personal favorite department), The Big Chill. As for television, you’ll recognize the tune in Supernatural, Cold Case, Northern Exposure, The Following, The Walking Dead, Teen Wolf, and not to be r elegated to the back of the line, Alvin and the Chipmunks, who belt out their own immensely irritating rendition.

hot stocks to invest in: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By Johanna Bennett]

    Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.

    Pessimism, meanwhile, appears to be on the rise.

    According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.

    Ihor Dusaniwsky at S3 Partners writes:

    RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.

    Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.

    Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.

    Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

hot stocks to invest in: Analog Devices, Inc.(ADI)

Advisors’ Opinion:

  • [By Lee Jackson]

    Analog Devices Inc. (NYSE: ADI) has been on a huge run, and a director at the chip company took advantage by selling a block of 50,000 shares of the stock at prices that ranged from $83.00 to $83.50. The total of the sale was set at $4 million. The shares ended Friday at $83.26, in a 52-week trading range is $52.17 to $84.24. The consensus price target is $89.42.

  • [By Leo Sun]

    If you think that Apple still has room to run, you should also check out three of its top suppliers — Cirrus Logic (NASDAQ:CRUS), Analog Devices (NASDAQ:ADI), and Skyworks Solutions (NASDAQ:SWKS) — which could all be lifted by the tech giant’s rally.

  • [By WWW.THESTREET.COM]

    Cramer was not bullish on Campbell Soup (CPB) , which also reports Tuesday, but did have good things to say about Tech Data (TECD) , Analog Devices (ADI) and Hewlett Packard Enterprise (HPE) , an Action Alerts PLUS holding.

hot stocks to invest in: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    The biotechs and emerging pharma havebeen under pressure from politicians attacking drug prices. That doesn’t mean that there are not some big winners out there. Sometimes the biggest winners are companies most investors have never heard of. Even if you have been a biotech and emerging pharma investor for years, chances are high that you would have never heard of a small outfit called Apricus Biosciences Inc. (NASDAQ: APRI).

hot stocks to invest in: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Steelcase Inc. (NYSE: SCS) was raised to Strong Buy from Market Perform at Raymond James.

    SUPERVALU Inc. (NYSE: SVU) was raised to Outperform from Sector Perform at RBC Capital Markets. Shares were indicated up 6% at $3.54 on Thursday.

  • [By Lisa Levin]

    Steelcase Inc. (NYSE: SCS) shares dropped 14 percent to $14.10 after the company reported downbeat earnings for its first quarter and issued a weak outlook for the second quarter.

  • [By Money Morning Staff Reports]

    These changes all emanate from the Ford Smart Mobility unit. Who ran that unit? New incoming Ford CEO Jim Hackett. Before joining Ford Mobility, Hackett was the corporate CEO of Steelcase Inc. (NYSE: SCS), where he transformed the company from a humdrum maker of desks to a designer of flexible, output-enhancing workspaces.

hot stocks to invest in: Aquinox Pharmaceuticals, Inc.(AQXP)

Advisors’ Opinion:

  • [By Lee Jackson]

    The Baker Brothers biotech hedge fund bought a block of 398,062 shares of Aquinox Pharmaceuticals Inc. (NASDAQ: AQXP) last week. At a per-shareprice of $17.18, the total for the trade came to$6,836,813.

Best Casino Stocks To Buy For 2018

Dec. 15, 2016, may just go down as the final piece of the “Abenomics” puzzle. Early on that morning, Japan’s parliament passed a bill that would finally legalize casinos. This sets the stage for billions of dollars to pour into the country. More importantly, Japanese Prime Minister Shinzo Abe is putting real weight behind his economic revival campaign.

Source: Flickr

But before you dive into casino stocks to buy, consider the enormous political and cultural opposition that was leveled against Japan casinos.

Best Casino Stocks To Buy For 2018: LivePerson Inc.(LPSN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology sector was the top gainer in the US market on Friday. Top gainers in the sector included LivePerson, Inc. (NASDAQ: LPSN), Vicor Corp (NASDAQ: VICR), and Broadcom Ltd (NASDAQ: AVGO).

  • [By Danny Vena]

    A recent survey of 5,000 consumers conducted by LivePerson, Inc. (NASDAQ:LPSN), a leading provider of mobile and online messaging solutions, found that 55% of consumers would prefer a bot over a human, but only in situations where the bot is just as accurate as a human representative. Just over 56%, though, would rather talk to a human, as many still believe that a human will understand what they need better than a bot. A full 89% of consumers globally have a neutral or positive perception of bots in general.

  • [By Dan Caplinger]

    But some stocks managed to buck the trend and give investors more upbeat outlooks for their prospects. SandRidge Energy (NYSE: SD), MBIA (NYSE:MBI), and LivePerson (NASDAQ:LPSN) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Best Casino Stocks To Buy For 2018: Fiat Chrysler Automobiles N.V.(FCAU)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Across the industry, days to turn averaged 72. The number was never below 60 in any month of 2016. It has gotten larger since the year has passed, up from 62 in January. Bycontrast with Subaru, the number for Fiat Chrysler Automobile N.V.’s (NYSE: FCAU) Ram pickup division was 128 in October. Dodge and Fiat were both over 100.

  • [By Jeremy Bowman]

    As for individual stocks, Fiat Chrysler(NYSE:FCAU) shares dove 10.3% after the EPA accused the automaker of cheating on emissions tests, similar to the way Volkswagendid. Elsewhere,Hess(NYSE:HES) shares dropped 4.8% after the oil company revealed $4.6 billion in charges for Q4 2016.

  • [By Dan Caplinger]

    Nevertheless, some stocks weren’t as lucky, and Fiat Chrysler Automobiles (NYSE:FCAU), AK Steel (NYSE:AKS), and Vista Outdoor (NYSE:VSTO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Douglas A. McIntyre]

    Image a car company with sales off 19% through the first 11 months of the year. Imagine a car company that routinely ranks at or near the bottom of the evaluations of Consumer Reports, J.D. Power rankings and the American Customer Satisfaction Index. Imagine a car company that routinely has 100 days of vehicle in inventory, compared to an industry average near70. That company isFiat, the small car division of Fiat Chrysler Automobiles N.V. (NYSE: FCAU).

  • [By Ben Levisohn]

    Yesterday, Volkswagen announced that it had reached a deal with U.S. Justice Department to pay $4.3 billion to settle charges that it had used software to cheat emission tests. Today, it’s Fiat Chrysler Automobiles’ (FCAU) turn to be in the spotlight after the EPA accused it of gaming emissions standards.

  • [By John Rosevear]

    But while President Trump has pushed GM, Ford, and Fiat Chrysler Automobiles (NYSE:FCAU) to move more production to the United States, he has also made a point of listening to their concerns.

Best Casino Stocks To Buy For 2018: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    The biotechs and emerging pharma havebeen under pressure from politicians attacking drug prices. That doesn’t mean that there are not some big winners out there. Sometimes the biggest winners are companies most investors have never heard of. Even if you have been a biotech and emerging pharma investor for years, chances are high that you would have never heard of a small outfit called Apricus Biosciences Inc. (NASDAQ: APRI).

which stock to buy today

Gold futures slipped Monday as the dollar flexed its strength against all major currencies save for the pound, dulling the appeal of the precious metal in the short term.

April gold GCG7, -0.28% fell $3.40, or 0.3%, to $1,231.00 an ounce. Gold futures ended lower Friday, but finished the week with a gain of more than 1%, for its sixth weekly rise in seven weeks.

which stock to buy today: Berkshire Hathaway Inc. (BRK-A)

Advisors’ Opinion:

  • [By Matthew Frankel]

    While it’s technically not a pure insurance stock, that’s exactly why I suggest Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) for investors who want a piece of the insurance business.

  • [By Daniel Sparks]

    3. Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B): Last, it would be a shame to overlook the conglomerate built by the world’s greatest investor himself, Warren Buffett. Under the Berkshire Hathaway name, Buffett has built up a portfolio of enduring subsidiaries and stock holdings poised to stand the test of time. Under Berkshire’s ownership are built-to-last subsidiaries like Geico, Duracell, and Burlington Northern Santa Fe Railway. And some of Berkshire’s largest stock holdings include iconic businesses like Coca-Cola, American Express, and Wells Fargo.

  • [By Jon C. Ogg]

    Investors and the public still seem to be enthralled by Warren Buffett and Berkshire Hathaway Inc. (NYSE: BRK-A). Many of those same people still know Bill Gates as well. Many people forget about the close ties between the two billionaires. A filing with the Securities andExchange Commission (SEC) on Monday should only serve to remind how deep the ties between Gates and Buffett go.

  • [By John Maxfield]

    Since the beginning of 2016, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has seen the value of the seven bank stocks in its investment portfolio increase by $5.6 billion, or 10.8%.

  • [By Bradley Seth McNew]

    Many analysts were excited by the prospect of Kraft and Heinz merging, sparked in part by Warren Buffett andBerkshire Hathaway(NYSE: BRK-A) (NYSE: BRK-B) taking about a 25% stake in the new entity. Turns out, those analysts were right, as the company has grown impressively throughout 2016.

  • [By Paul Ausick]

    Among other stories related to the company last week, Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) reported that it now owns about 57.4 million shares of Apple stock, up from 15.23 million at the end of the third quarter of 2016.

which stock to buy today: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    The biotechs and emerging pharma havebeen under pressure from politicians attacking drug prices. That doesn’t mean that there are not some big winners out there. Sometimes the biggest winners are companies most investors have never heard of. Even if you have been a biotech and emerging pharma investor for years, chances are high that you would have never heard of a small outfit called Apricus Biosciences Inc. (NASDAQ: APRI).

which stock to buy today: Partner Communications Company Ltd.(PTNR)

Advisors’ Opinion:

  • [By Monica Gerson]

    Partner Communications Company Ltd (ADR) (NASDAQ: PTNR) is expected to post earnings for the recent quarter.

    Noah Holdings Limited (ADR) (NYSE: NOAH) is estimated to post financial results for its latest quarter.

which stock to buy today: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By James E. Brumley]

    Are hemp and marijuana one and the same? It depends who you ask. The federal government accurately recognizes that hemp and marijuana are variants of the same species, Cannabis sativa. Yet, poodles and German shepherds are also from the same species, and the two couldn’t be any more different types of dogs. The same goes for marijuana and hemp. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), which is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.

    The good news is, governments – federal and state – are finally starting to wise up to the distinct differences between marijuana and hemp, and that bodes well for a young startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

    Lexaria Bioscience Corp. is “a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.”

    In other words, it solves a problem within the budding (no pun intended) world of cannabis and medical — or even recreational — marijuana. It increases the amount of absorption of a substance ingested.

    The science has applications in everything from vitamins to supplements to painkillers, but LXRP is starting with the hemp oil for good reason.

    Hemp seeds (which are technically a nut and are als

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

  • [By Matthew Briar]

    Granted, it’s not always a fully-appreciated distinction. Even though the federal government accurately recognizes that hemp and marijuana are only variants of the same species, Cannabis sativa, the DEAdoesn’t necessarily enforce its drug laws as such. For legitimate medical purposes, the government is perfectly willing to leave the matter alone.

    The good news is, governments – federal as well as state – are finally starting to figure out the distinct differences between marijuana and hemp, and that bodes well for a young and hungry startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

  • [By Bryan Murphy]

    Though they’re not the same thing, anything that’s good for marijuana is good for hemp. That’s why when eight out of nine states that had marijuana on the ballot two Tuesday’s ago approved those measures, things got a lot more compelling for owner of Lexaria Bioscience Corp (OTCMKTS:LXRP).

    What’s the difference? Hemp a strains of Cannabis sativa that have been bred specifically for fiber used for clothing, construction, oils and topical ointments, nutritional benefits and a wide array of other purposes that don’t involve getting “high.” Marijuana is a slang term used to describe strains of Cannabis sativa that are bred for the potent resinous glands, or trichomes, that grow on the flowers and some leaves… the strain packed with tetrahydrocannabinol (or THC).

    They would be easy to confuse, and commonly are. The potential for confusion, in fact, is the chief reason government agencies have been hesitant to support one and ban the other. With marijuana now legalized for use for one reason or another in more than half the United States though, knowledge and understanding of the difference will soon follow.

    Great, but what’s that got to do with Lexaria Bioscience is on the leading edge of the movement of heightened understanding of what hemp is, and what it does.

    The medical benefits of the non-psychoactive form of Cannabis sativa are impressive to say the least. Among other benefits, hempseed oil has also shown a positive effect on dermatological diseases and lipid metabolism (the process by which fatty acids are broken down in the body). Hempseed also has high levels of vitamins A, C and E and ?-carotene, and it is rich in minerals like phosphorus, potassium, magnesium, sulfur and calcium. As a food, hempseed oil is nutritious – it contains an excellent balance of polyunsaturated fatty acids – and it reportedly tastes good, too.

    Problem: Hemp isn’t effectively absorbed into the body, and as such, it’s difficult to make effec

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Jim Robertson]

    In October, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP) was issuedU.S. Patent No. 9,474,725 Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof and now the company is seeking to expand this patent internationally. This patent protects Lexaria Bioscience Corps intellectual property related to infusion of cannabinoid compounds in edible products and includes a set of claims that describe the Companys method of combining a fatty acid compound with any non-psychoactive cannabinoid for improved bioavailability and taste performance in both food and beverage formats.